Patent AnalyticsExaminers
Menu

Application

19626271 · iRNA Compositions and Methods for Silencing Growth Factor Receptor Bound Protein 14 (GRB14) in the Liver

Filed 2026-09-21 · Pending The official file ↗ · Art unit · ALNYLAM PHARMACEUTICALS, INC. · WOMBLE BOND DICKINSON (US) LLP/Alnylam Pharmaceuti

Office actions
0
first was
RCEs
0
no appeal
To first action
n/a
to disposition n/a
Statutes raised
·
0 actions read
Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in